KATE vs Regard
Regard is sold partly to finance buyers. The vendor says it reviews 100% of the chart, recommends diagnoses with an evidence chain and drafts notes, and that no diagnostic logic reaches patients without physician approval. Its solutions include HCC Capture and a mid-revenue-cycle product for missed diagnoses before denials. Regard holds an ONC Health IT certification under the 2015 Cures Update, dated May 2024, shows Epic over FHIR R4 in its demo, and shows Banner Health, WakeMed and Kettering Health among its customers. The vendor's Sentara case study reports 17% more CC/MCC capture and 4x ROI per user.
Mednition's customer is the ED nursing director, and the vendor's 2019 study claimed 26.9% higher triage accuracy, with the paper then in peer review. Regard works on diagnoses and revenue capture across a hospital and KATE on acuity at the ED door, so the two do different jobs.
Decision support · Reviewed November 2, 2026
When to pick each one
KATE
- Vendor-run 2019 study claims 26.9% better triage accuracy
- Triage acuity and sepsis risk for the ED
Regard
- ONC Health IT certification, 2015 Cures Update, May 2024
- Epic over FHIR R4 shown in demo
- HCC capture and denial prevention modules
Score
Each row shows points earned of points available under the published rubric.
KATE
12of 100
Regard
9of 100
| Dimension | KATE | Regard | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 5.6 | 1.7 / 5.6 | -1.7 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 1.9 / 4.8 | -1.9 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 0 / 21 | 0 / 21 | 0 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 6 / 6 | 0 / 6 | +6 |
Scroll horizontally to see every column.
Pricing
KATE
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Regard
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
KATE
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Regard
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | KATE | Regard |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Epic |
| Founded | 2014 | n/a |
| HQ | US | n/a |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.


